Antipsychotic profile of 5-{2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl}-4-(4-fluorophenyl) thiazole-2-carboxylic acid amide (NRA0562) in rats

Life Sciences

Volumn 71, Issue 8, 2002, Pages 947-952

  Takamori, Kazuaki ^a   Funakoshi, Takeo ^a   Hirota, Shiho ^a   Chaki, Shigeyuki ^a   Kameo, Kazuya ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Clozapine; Conditioned avoidance; Haloperidol; NRA0562; Risperidone

Indexed keywords

5 [2 [4 (6 FLUORO 1H INDOL 3 YL)PIPERIDIN 1 YL]ETHYL] 4 (4 FLUOROPHENYL)THIAZOLE 2 CARBOXYLIC ACID AMIDE; ALPHA 1 ADRENERGIC RECEPTOR; CLOZAPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; HALOPERIDOL; NEUROLEPTIC AGENT; NRA 0562; RISPERIDONE; SEROTONIN 2A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; BINDING AFFINITY; CONDITIONING; CONTROLLED STUDY; DIAGNOSTIC TEST; DOSE RESPONSE; MALE; NONHUMAN; RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HALOPERIDOL; MALE; PIPERIDINES; RATS; RATS, WISTAR; RISPERIDONE; THIAZOLES;

EID: 0037067488     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)01766-6     Document Type: Article

References (22)

1. Differential effects of neuroleptic and other psychotic agents on acquisition of avoidance in rats
2. Potency mismatch for behavioral and biochemical effects by dopamine receptor antagonists: Implications for the mechanism of action of clozapine
3. A systematic study of the pharmacological activities of dopamine antagonists
4. Atypical antipsychotic properties of NRA0562
5. Neuropharmacological profiles of a novel atypical antipsychotic, 5-{2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl}-4-(4-fluorophenyl) thiazole-2-carboxylic acid amide (NRA0562), in rats
6. Ziprasidone (CP-88,059): A new antipsychotic with combined dopamine and serotonin receptor antagonist activity
7. 1A agonist properties: II. Functional profile in comparison to clozapine and haloperidol
8. 2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0562)
9. The behavioral pharmacology of olamzapine, a novel "atypical" antipsychotic agent
10. S33084, a novel, potent, selective, and competitive at dopamine(3) receptors: II. Functional and behavioral profile in compared with GR18,231 and LY741,626
11. Clinical studies on the mechanism of action of clozapine: The dopamine-serotonin hypothesis of schizophrenia
12. 2 pKi values
13. Effect of a serotonin antagonist in schizophrenia: A pilot study with setoperone
14. 1-adrenoceptor antagonism
15. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist
16. 2 receptor blocking agent, ritanserin, in the rat
17. 2 receptor antagonist raclopride in rats
18. 2 receptors
19. 2 antagonists in male mice
20. 7-Methyl-6,7,8,9,14,15-hexahydro-5H-benz[d]indolo[2,3-g]azecline: A new heterocyclic system and a new lead compound for dopamine receptor antagonists
21. Determination of plasma and brain concentrations SCH39166 and their correlation to conditioned avoidance behavior in rats
22. L-754,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests